GlassScriptPhysician profile
Kaitlyn Hall
NPI 1548829385
$3,089.48
in general payments reported to CMS, 2019-2025
28 companies · $863 in 2025
The $863 reported for 2025 was more than what 83% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $554 · 2022: $824 · 2023: $446 · 2024: $401 · 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,359 · Travel and Lodging: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.40 |
| Travel and Lodging | $351.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $721.84 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $604.39 | 2021-2024 | Relistor |
| Boston Scientific Corporation | $603.56 | 2023-2025 | General - Therapies, Wavewriter Alpha Prime 16 |
| Radius Health, INC. | $219.96 | 2021-2025 | Tymlos |
| Amgen INC. | $139.69 | 2024-2025 | Evenity, Prolia, Prolia |
| Medtronic, INC. | $122.95 | 2022 | |
| Virtus Pharmaceuticals LLC | $67.14 | 2021 | |
| Redhill Biopharma INC. | $65.55 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $57.64 | 2021 | |
| Collegium Pharmaceutical, INC. | $52.09 | 2022-2025 | Belbuca |
| Almatica Pharma LLC | $51.20 | 2021 | |
| Grt US Holding, INC. | $36.45 | 2022 | |
| Pfizer INC. | $32.45 | 2023 | |
| Abbott Laboratories | $28.69 | 2025 | Eterna |
| Lundbeck LLC | $27.96 | 2024 | Vyepti |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $26.33 | 2023 | |
| Biotronik Nro, INC. | $23.88 | 2025 | Prospera |
| Vertex Pharmaceuticals Incorporated | $23.67 | 2025 | |
| Si-Bone, INC. | $22.35 | 2021 | |
| Averitas Pharma INC. | $21.96 | 2024 | Qutenza |
| Biohaven Pharmaceutical Holding Company LTD. | $21.60 | 2022 | |
| Saluda Medical Americas, INC. | $21.03 | 2025 | Evoke |
| Amneal Pharmaceuticals LLC | $19.24 | 2022 | |
| Scilex Pharmaceuticals INC. | $18.74 | 2021 | |
| Mdd US Operations, LLC | $17.72 | 2022 | |
| Biodelivery Sciences International, INC. | $16.26 | 2021 | |
| Allergan, INC. | $13.32 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $11.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlyn Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.